Page last updated: 2024-12-10

axerophthene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

axerophthene: hydrocarbon analog of retinol; RN given refers to (all-E)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

axerophthene : A diterpene that is cyclohexene substituted by a (1Z,3E,5E,7E)-3,7-dimethylnona-1,3,5,7-tetraen-1-yl group at position 2 and by methyl groups at positions 1,3 and 3. It is the parent hydrocarbon on which Vitamin A and other retinoids are based. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5287722
CHEMBL ID67791
CHEBI ID40918
MeSH IDM0066145

Synonyms (22)

Synonym
cyclohexene, 2-(3,7-dimethyl-1,3,5,7-nonatetraenyl)-1,3,3-trimethyl-, (all-e)-
6895-29-0
axerophthene
all-trans axerophthene
LMPR0104020002
CHEMBL67791
2-[(1e,3e,5e,7e)-3,7-dimethylnona-1,3,5,7-tetraenyl]-1,3,3-trimethylcyclohexene
4I9S
4I9R
4EXZ
4EDE
4GKC
4EFG
4EEJ
2-[(1e,3e,5e,7e)-3,7-dimethylnona-1,3,5,7-tetraen-1-yl]-1,3,3-trimethylcyclohexene
Q27458141
(all-e)-2-(3,7-dimethyl-1,3,5,7-nonatetraenyl)-1,3,3-trimethylcyclohexene
CHEBI:40918
2-[(1e,3e,5e,7e)-3,7-dimethylnona-1,3,5,7-tetraen-1-yl]-1,3,3-trimethylcyclohex-1-ene
deoxyretinol
axerophten
(all-e)-3,7-dimethyl-1-(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-2,4,6-nonatriene

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
diterpeneA C20 terpene.
polyeneAn olefin that contains more than one carbon-carbon double bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain B, Retinol-binding protein 2Homo sapiens (human)Kd0.06920.02900.06920.1500AID977611
Chain A, Retinol-binding protein 2Homo sapiens (human)Kd0.06920.02900.06920.1500AID977611
Chain A, Retinol-binding protein 2Homo sapiens (human)Kd0.06920.02900.06920.1500AID977611
Chain A, Retinol-binding protein 2Homo sapiens (human)Kd0.06920.02900.06920.1500AID977611
Chain A, Retinol-binding protein 2Homo sapiens (human)Kd0.06920.02900.06920.1500AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2012Science (New York, N.Y.), Dec-07, Volume: 338, Issue:6112
Tuning the electronic absorption of protein-embedded all-trans-retinal.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Journal of the American Chemical Society, Oct-30, Volume: 135, Issue:43
Rational design of a colorimetric pH sensor from a soluble retinoic acid chaperone.
AID199395Dissociation constant with retinol binding protein was determined; No data2000Bioorganic & medicinal chemistry letters, Sep-18, Volume: 10, Issue:18
HINT predictive analysis of binding between retinol binding protein and hydrophobic ligands.
AID19234Partition coefficient (logP)2000Bioorganic & medicinal chemistry letters, Sep-18, Volume: 10, Issue:18
HINT predictive analysis of binding between retinol binding protein and hydrophobic ligands.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]